Form 4: USANA Health Sciences Director, John Turman Fleming, Sells 500 Shares
SEC Form 4 Filing
Director John Turman Fleming sold 500 shares of USANA Health Sciences Inc. on March 11, 2025, at a price of $33.2954 per share.
Summary
- On March 11, 2025, John Turman Fleming, a director of USANA Health Sciences Inc., sold 500 shares of common stock.
- The transaction was executed at a price of $33.2954 per share.
- Following the transaction, Fleming directly owns 4,026 shares of USANA Health Sciences Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sentiment is neutral as it simply reports the sale of shares by a company director.
Industry Context
This is a routine disclosure of insider trading activity. It is important to monitor insider transactions as they can provide insights into management's perspective on the company's future prospects, although a single sale is not necessarily indicative of a trend.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although the relatively small number of shares sold is unlikely to have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of transaction: John Turman Fleming sold 500 shares of USANA Health Sciences Inc. |
| 03/12/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.